Fresenius Medical Care AG (XSWX:FME) Momentum Rank: 7 (As of Jul. 25, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FME Fresenius Medical Care AG XSWX:FME
75 GF Score
Price CHF39.25
GF Value CHF37.64
! 4 Warning Signs
View Full Analysis

What is Fresenius Medical Care AG Momentum Rank?

Fresenius Medical Care AG XSWX:FME +0.44% 75 Momentum Rank is 7 as of Jul. 25, 2026, which is at its 10-year median of 7.00. GuruFocus rates XSWX:FME with a GF Score™ of 75/100 and a GF Value™ of CHF37.64. The stock has 4 warning signs investors should review.

Fresenius Medical Care AG has the Momentum Rank of 7.

Momentum Rank measures the strength and persistence of a stock's price movement over time, rated on a scale of 1 to 10.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

A higher score reflects strong price momentum and indicates greater potential for superior performance. Conversely, a lower score indicates that momentum is either too high or too low, and stocks tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Fresenius Medical Care AG Momentum Rank Related Terms

XSWX:FME vs HCA, THC, DVA: Momentum Rank Comparison

For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Momentum Rank, along with its competitors' market caps and Momentum Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fresenius Medical Care AG Momentum Rank vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Momentum Rank distribution charts can be found below:

* The bar in red indicates where Fresenius Medical Care AG's Momentum Rank falls into.


XSWX:FME
75GF Score
Fresenius Medical Care AG XSWX:FME
Momentum Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Momentum Rank →
What does a Momentum Rank of 7 mean?
Fresenius Medical Care AG (XSWX:FME) has a Momentum Rank of 7 as of Jul. 25, 2026. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Fresenius Medical Care AG and its competitors. This is near median its historical median of 7.00. Over the past decade, Fresenius Medical Care AG's Momentum Rank has ranged from 1.00 to 10.00.
Is Fresenius Medical Care AG's Momentum Rank too high?
Fresenius Medical Care AG's current Momentum Rank of 7 is near median its 10-year median of 7.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 10.00. Overall, Fresenius Medical Care AG has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Momentum Rank compare to HCA and THC?
Fresenius Medical Care AG's Momentum Rank of 7 can be compared against companies in the Healthcare Providers & Services industry. Historically, Fresenius Medical Care AG's own Momentum Rank has ranged from 1.00 to 10.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Momentum Rank for a Healthcare Providers & Services company?
A good Momentum Rank depends on the Healthcare Providers & Services industry context. However, Momentum Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Momentum Rank mean?
A high Momentum Rank can signal that a stock is expensive relative to its fundamentals. Momentum Rank is determined using the standardized momentum ratio, measuring the speed and velocity of price changes in a stock. View historical data on Fresenius Medical Care AG and its competitors. Fresenius Medical Care AG's current Momentum Rank is 7, which is near median its own 10-year median of 7.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Fresenius Medical Care AG (XSWX:FME) has a current Momentum Rank of 7. The stock's GF Value™ is CHF37.64, compared to a current price of CHF39.25 — trading 4.3% above its estimated fair value. The current Momentum Rank is 7, which is near median its 10-year median of 7.00. Fresenius Medical Care AG's overall GF Score™ is 75/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Momentum Rank calculated?
Momentum Rank is calculated from a company's financial statements. For Fresenius Medical Care AG (XSWX:FME), the current Momentum Rank is 7 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius Medical Care AG (XSWX:FME) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be overvalued. The current stock price of CHF39.25 is trading 4.3% above its estimated GF Value™ of CHF37.64.

Key valuation signals for XSWX:FME:

  • Momentum Rank: 7 (near median its 10-year median of 7.00)
  • GF Value™: CHF37.64 vs. price of CHF39.25 (4.3% above fair value)
  • GF Score™: 75/100 with 4 warning signs

No single metric tells the full story. See the XSWX:FME stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius Medical Care AG Business Description

Address Else-Kroner-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
75GF Score

Get the complete analysis for XSWX:FME

Momentum Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF39.25
Price
CHF37.64
GF Value